Vita Life Sciences Ltd (AU:VLS) — Market Cap & Net Worth
Market Cap & Net Worth: Vita Life Sciences Ltd (VLS)
Vita Life Sciences Ltd (AU:VLS) has a market capitalization of $100.48 Million (AU$142.01 Million) as of August 20, 2026. Listed on the AU stock exchange, this Australia-based company holds position #19269 globally and #626 in its home market, demonstrating a 4.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vita Life Sciences Ltd's stock price AU$2.60 by its total outstanding shares 54620353 (54.62 Million). See how leveraged is Vita Life Sciences Ltd's balance sheet to understand what proportion of total assets are financed by equity.
Vita Life Sciences Ltd Market Cap History: 2015 to 2026
Vita Life Sciences Ltd's market capitalization history from 2015 to 2026. Data shows growth from $37.53 Million to $100.48 Million (13.88% CAGR). Also see Vita Life Sciences Ltd balance sheet assets for a full breakdown of the balance sheet.
Vita Life Sciences Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vita Life Sciences Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check VLS share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.97x
Vita Life Sciences Ltd's market cap is 0.97 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.80x
Vita Life Sciences Ltd's market cap is 8.80 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $37.53 Million | $38.58 Million | $4.39 Million | 0.97x | 8.55x |
| 2016 | $35.85 Million | $37.86 Million | $3.34 Million | 0.95x | 10.72x |
| 2017 | $22.20 Million | $37.74 Million | $2.86 Million | 0.59x | 7.75x |
| 2018 | $28.99 Million | $41.15 Million | $2.44 Million | 0.70x | 11.89x |
| 2019 | $21.07 Million | $42.45 Million | $3.14 Million | 0.50x | 6.72x |
| 2020 | $33.10 Million | $46.48 Million | $6.09 Million | 0.71x | 5.43x |
| 2021 | $65.83 Million | $57.10 Million | $8.29 Million | 1.15x | 7.94x |
| 2022 | $48.36 Million | $66.89 Million | $7.08 Million | 0.72x | 6.83x |
| 2023 | $66.04 Million | $74.16 Million | $9.08 Million | 0.89x | 7.27x |
| 2024 | $77.29 Million | $79.50 Million | $8.78 Million | 0.97x | 8.80x |
Competitor Companies of VLS by Market Capitalization
Companies near Vita Life Sciences Ltd in the global market cap rankings as of August 20, 2026. Also see VLS cash flow metrics for how efficiently the company converts equity into cash flow.
Key companies related to Vita Life Sciences Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #520 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #559 globally with a market cap of $48.88 Billion USD ( CN¥334.07 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #564 globally with a market cap of $48.49 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #636 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #520 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #559 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $48.88 Billion | CN¥52.37 |
| #564 | GALDERMA GROUP AG | NYSE:GALDY | $48.49 Billion | $41.59 |
| #636 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €15.20 |
Vita Life Sciences Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Vita Life Sciences Ltd's market cap moved from $37.53 Million to $ 100.48 Million, with a yearly change of 13.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$100.48 Million | +0.78% |
| 2025 | AU$99.71 Million | +29.00% |
| 2024 | AU$77.29 Million | +17.03% |
| 2023 | AU$66.04 Million | +36.58% |
| 2022 | AU$48.36 Million | -26.55% |
| 2021 | AU$65.83 Million | +98.90% |
| 2020 | AU$33.10 Million | +57.08% |
| 2019 | AU$21.07 Million | -27.32% |
| 2018 | AU$28.99 Million | +30.61% |
| 2017 | AU$22.20 Million | -38.08% |
| 2016 | AU$35.85 Million | -4.50% |
| 2015 | AU$37.53 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 19th, 2026 the market cap of Vita Life Sciences Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $100.48 Million USD |
| MoneyControl | $100.48 Million USD |
| MarketWatch | $100.48 Million USD |
| marketcap.company | $100.48 Million USD |
| Reuters | $100.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vita Life Sciences Ltd
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands… Read more